NCT02186496View on ClinicalTrials.gov

Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

November 30, 2014

Conditions
Hypertension
Interventions
DRUG

CKD-330 8/5mg

DRUG

Candesartan 8mg and Amlodipine 5mg

Trial Locations (1)

301-721

Chungnam National University Hospital, Daejeon

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT02186496 - Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg) | Biotech Hunter | Biotech Hunter